CAPAX
Price
$9.69
Change
+$0.02 (+0.21%)
Updated
Jul 31 closing price
Net Assets
668.75M
VTMFX
Price
$50.90
Change
+$0.13 (+0.26%)
Updated
Jul 31 closing price
Net Assets
12.25B
Interact to see
Advertisement

CAPAX vs VTMFX

CAPAX vs VTMFX Comparison Chart in %
View a ticker or compare two or three
VS
CAPAX vs. VTMFX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPAX is a Buy and VTMFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTMFX has more cash in the bank: 12.3B vs. CAPAX (669M). CAPAX pays higher dividends than VTMFX: CAPAX (3.45) vs VTMFX (2.22). CAPAX was incepted earlier than VTMFX: CAPAX (38 years) vs VTMFX (32 years). CAPAX (1.12) is less costly to investors than VTMFX (0.05). CAPAX is a more actively managed with annual turnover of: 27.00 vs. VTMFX (15.00). CAPAX has a lower initial minimum investment than VTMFX: CAPAX (1500) vs VTMFX (10000). CAPAX annual gain was more profitable for investors over the last year : 11.20 vs. VTMFX (8.85). CAPAX (28.46) and VTMFX (28.44) have equivalent 5 years return.
CAPAXVTMFXCAPAX / VTMFX
Total Expense Ratio0.900.051,800%
Annual Report Gross Expense Ratio1.120.052,240%
Fund Existence38 years32 years-
Gain YTD5.3653.413157%
Front Load5%N/A-
Min. Initial Investment15001000015%
Min. Initial Investment IRA250N/A-
Net Assets669M12.3B5%
Annual Yield % from dividends3.452.22156%
Returns for 1 year11.208.85127%
Returns for 3 years36.2730.02121%
Returns for 5 years28.4628.44100%
Returns for 10 years76.0393.0082%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPFCX20.310.25
+1.25%
PGIM Jennison Focused Growth C
WMLIX36.250.22
+0.61%
Wilmington Large-Cap Strategy Instl
MSACX21.730.10
+0.46%
Morgan Stanley Inst Passport ovrs eq I
RALOX11.74-0.05
-0.42%
Lazard Real Assets Open
SHISX61.73-0.68
-1.09%
BlackRock Health Sciences Opps Svc